Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Democrats Take Plan B Battle To Appropriations Bill

This article was originally published in The Tan Sheet

Executive Summary

An amendment intended to support the over-the-counter switch of emergency contraceptive Plan B (levonorgestrel) survived debate on the House floor July 13
Advertisement

Related Content

Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
Plan B Decision Mobilizes House Members To Seek FDA Integrity Review
CDER’s Galson Cites Application Flaws, Not Politics, In Plan B Decision
CDER’s Galson Cites Application Flaws, Not Politics, In Plan B Decision
Plan B Behind-The-Counter Status Discouraged By Panel Members

Topics

Advertisement
UsernamePublicRestriction

Register

PS097066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel